High-intensity focused ultrasound (HIFU) for the prostate cancer at 976 patients: 7-year experience

HIFU shows a successful treatment for localized prostate cancer. Here we explored the effectiveness of the HIFU treatment for the prostate cancer, hormone-resistant prostate cancer and failure after external beam radiotherapy and radical prostatectomy. 976 patients were treated in our centre in 2007 - 2014: Kaplan-Meir analyses of the total group indicated that the survival was 79,2 % after 7 years of follow-up. Our experience shows that HIFU ablation is safe, minimally invasive, effective treatment with moderate side effects for the PC, hormone-resistant prostate cancer, HIFU also may be used as a salvage therapy.